New dietary supplement – vitamin K
We present a new product – dietary supplement “Vitamin K2 MK-7 (menaquinone-7)”.
Vitamin K2 (menaquinone) is a fat-soluble vitamin that is involved in the regulation of blood clotting.Vitamin K is necessary for the proper functioning of vitamin K-dependent proteins, of which there are 14 in the body. These include blood clotting factors, protein C, protein S, produced in the liver; transmembrane proteins; bone tissue proteins - osteocalcin, MGP (Matrix Gla-protein - proteins whose function is regulated by vitamin K).
Vitamin K2 activates proteins involved in calcium metabolism, so it has a positive effect on the functioning of the heart and blood vessels, brain, liver, bone and dental health.
When combined with vitamin D, vitamin K2 has a synergistic, positive effect on bone density. It also stimulates the calcification of cartilage tissue, strengthens the structure of the intervertebral rings, and counteracts the development of degenerative osteoarthritis - in particular spondyloarthrosis.
PHARMAKOR PRODUCTION plans to produce this dietary supplement in capsules containing 2 capsules (daily dose) of 200 mcg of vitamin K2, which is 167% of the established standards, but does not exceed the UPL (upper permissible level).